1. Sweden Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Promimic AB

Promimic AB

9.55
SEK
0.00
(0.00%)
-0.41EPS
188.92MMarket Cap
Promimic AB
STO:PRO
(Nasdaq Stockholm)

Recent

price

9.55

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
SEK
0.33
0.32
0.46
1.03
2.01
2.34
2.35
2.39
Revenue per Share
-0.65
-0.79
-0.87
-1.01
-0.5
-0.67
-0.46
-0.41
Basic EPS, GAAP
- -
- -
-0.89
-1.44
-0.71
-1.08
-0.69
-0.11
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
1.49
2.14
1.3
4.41
4.11
3.7
3.13
2.89
Book Value per Share
0.78
1.46
0.67
3.6
3.29
2.72
1.92
1.68
Tangible Book Value per Share
17
17
17
16
18
19
19
19
Basic Weighted Avg Shares
6
6
8
16
37
44
44
45
Sales/Revenue/Turnover
-193.91
-254.92
-190.73
-100.98
-27.08
-19.96
-20.88
-18.27
Operating Margin (%)
2
2
2
3
4
5
5
5
Depreciation Expense
-11
-14
-15
-16
-9
-13
-9
-8
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-196.67
-245.98
-188.26
-97.98
-24.88
-28.54
-19.71
-17.11
Profit Margin (%)
12
24
9
58
48
41
25
22
Working Capital
- -
- -
2
- -
- -
- -
- -
- -
LT Debt
26
37
23
81
77
70
59
55
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-43.36
-50.76
-30.59
-11.67
-17.12
-13.57
-13.23
Return on Common Equity (%)

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
19
19
Market Capitalization
320
260
189

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
42
38
36
Cash, Cash Equivalents & STI
21
22
20
Accounts Receivable, Net
12
15
16
Inventories
1
1
1
Total Current Liabilities
17
15
14
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
38.17%
-15.46%
Free Cash Flow
- -
- -
-36.07%
Net Income, GAAP
- -
-4.14%
-30.25%
Sales/Revenue/Turnover
- -
58.81%
1.01%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9
12
11
13
44
2025
9
11
13
11
44
2026
9
12
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.19
-0.14
-0.08
-0.26
-0.67
2025
-0.24
-0.08
-0.06
-0.08
-0.46
2026
-0.18
-0.08
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Promimic AB (publ) develops and commercializes advanced biomaterial solutions designed to enhance the integration of medical implants with bone. The company's core offering, HAnano Surface technology, provides a nanoscale, hydroxyapatite coating that mimics natural bone structure, significantly improving osseointegration and promoting faster healing for orthopedic and dental applications. This innovative surface treatment is applicable across a variety of implant materials and geometries. Promimic operates on a licensing model, partnering with leading implant manufacturers, and has expanded its presence, notably establishing Nano Processing Inc. in the U.S. through a joint venture to serve the North American market. Founded in 2004, the company maintains its headquarters in Mölndal, Sweden, with its technology now clinically utilized in millions of implants globally.